Tumor angiogenesis is one of the most prominent mechanisms driving tumor development and progression. This book is written by internationally rewned experts. Part 1 describes the basic mechanisms. Tumor-angiogenic signaling pathways are presented as new potential targets for anti-angiogenic therapy. Part 2 reviews the efforts made to validate new targets and to show efficacy in animals. Part 3 is devoted to the clinical development of the vel anti-angiogenic drugs and their use in clinical practice.
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Date of Publication
Clinical Medicine: Professional
Place of Publication
Country of Publication
Springer-Verlag Berlin and Heidelberg GmbH & Co. K